Comparison of Machine Learning Models for Classification of Breast Cancer Risk Based on Clinical Data
- PMID: 40176498
- PMCID: PMC11965882
- DOI: 10.1002/cnr2.70175
Comparison of Machine Learning Models for Classification of Breast Cancer Risk Based on Clinical Data
Abstract
Background: Breast cancer (BC) is a major global health concern with rising incidence and mortality rates in many developing countries. Effective BC risk assessment models are crucial for prevention and early detection. While the Gail model, a traditional logistic regression-based model, has been broadly used, its predictive performance may be limited by its linear assumptions. With the rapid advancement of artificial intelligence (AI) in medical sciences, various complex machine learning algorithms have been developed for risk prediction, including for BC.
Aims: This study aims to compare the quality of AI-based models with the traditional Gail model in assessing BC risk using a population dataset. It also evaluates the performance of these models in predicting BC risk.
Methods and results: This study involved 942 newly diagnosed BC patients and 975 healthy controls at the Cancer Institute in IKH hospital Complex, Tehran. Ten classification algorithms were applied to the dataset. The accuracy, sensitivity, precision, and feature importance in the machine learning algorithms were assessed and compared to previous studies for evaluation. The study found that AI algorithms alone did not significantly improve predictability compared to the Gail model. However, the importance of variables varied significantly among the AI algorithms. Understanding feature importance and interactions is crucial in AI modeling in order to enhance accuracy and identify critical risk factors.
Conclusion: This study concluded that, in BC risk prediction, incorporating specific risk factors, such as genetic and image-related variables, may be necessary to further enhance accuracy in BC risk prediction models. Furthermore, it is crucial to address modeling issues in models with a restricted number of features for future research.
Keywords: artificial intelligence; breast cancer; conventional models; machine learning; risk assessment.
© 2025 The Author(s). Cancer Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Artificial intelligence for breast cancer detection and its health technology assessment: A scoping review.Comput Biol Med. 2025 Jan;184:109391. doi: 10.1016/j.compbiomed.2024.109391. Epub 2024 Nov 22. Comput Biol Med. 2025. PMID: 39579663
-
Predicting HER2 Status Associated with Breast Cancer Aggressiveness Using Four Machine Learning Models.Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3609-3618. doi: 10.31557/APJCP.2024.25.10.3609. Asian Pac J Cancer Prev. 2024. PMID: 39471028 Free PMC article.
-
An Advanced Machine Learning Model for a Web-Based Artificial Intelligence-Based Clinical Decision Support System Application: Model Development and Validation Study.J Med Internet Res. 2024 Sep 4;26:e56022. doi: 10.2196/56022. J Med Internet Res. 2024. PMID: 39231422 Free PMC article.
-
An advanced machine learning method for simultaneous breast cancer risk prediction and risk ranking in Chinese population: A prospective cohort and modeling study.Chin Med J (Engl). 2024 Sep 5;137(17):2084-2091. doi: 10.1097/CM9.0000000000002891. Epub 2024 Feb 26. Chin Med J (Engl). 2024. PMID: 38403898 Free PMC article.
-
Promoting Artificial Intelligence for Global Breast Cancer Risk Prediction and Screening in Adult Women: A Scoping Review.J Clin Med. 2024 Apr 25;13(9):2525. doi: 10.3390/jcm13092525. J Clin Med. 2024. PMID: 38731054 Free PMC article.
References
-
- Sung H., Ferlay J., Siegel R. L., et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 71, no. 3 (2021): 209–249. - PubMed
-
- Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., and Jemal A., “Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 68, no. 6 (2018): 394–424. - PubMed
-
- Gail M. H., Brinton L. A., Byar D. P., et al., “Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually,” Journal of the National Cancer Institute 81, no. 24 (1989): 1879–1886. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical